Federated Hermes, Inc. Hutchmed (China) LTD Transaction History

Federated Hermes, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$8.59 - $20.77 $3.81 Million - $9.2 Million	-443,157 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$15.52 - $35.65 $254,528 - $584,660	-16,400 Reduced 3.57%	443,157 $8.39 Million
Q4 2021 Feb 14, 2022	BUY	$28.89 - $35.33 $13.3 Million - $16.2 Million	459,557 New	459,557 $16.1 Million

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.9B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.